Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - codeine phosphate hemihydrate, quantity: 10 mg; doxylamine succinate, quantity: 5.1 mg; paracetamol, quantity: 499.95 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; crospovidone; povidone; stearic acid; self-emulsifying glyceryl monostearate; pregelatinised maize starch - for the temporary relief of acute moderate pain and fever

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; maize starch; povidone; crospovidone; stearic acid; colloidal anhydrous silica - codalgin forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - codeine phosphate hemihydrate 9.75mg;  ; doxylamine succinate 5mg;  ;  ; paracetamol 450mg (as compap l 500mg);   - tablet - active: codeine phosphate hemihydrate 9.75mg   doxylamine succinate 5mg     paracetamol 450mg (as compap l 500mg)   excipient: magnesium stearate maize starch microcrystalline cellulose purified talc quinoline yellow sodium starch glycolate sunset yellow fcf - for patients over the age of 12 for the symptomatic relief of acute moderate to severe pain including headache, toothache, backache or pain associated with trauma or surgery. the calmative properties may be especially useful in the treatment of tension headache, migraine and period pain and the antipyretic properties may be useful in controlling fever. mersyndol is a suitable alternative for those individuals who cannot tolerate aspirin.

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - codeine phosphate hemihydrate 9.75mg; doxylamine succinate 5mg;  ;  ; paracetamol 450mg;   - tablet - 9.75mg/5mg/450mg - active: codeine phosphate hemihydrate 9.75mg doxylamine succinate 5mg     paracetamol 450mg   - for patients over the age of 12 for the symptomatic relief of acute moderate to severe pain including headache, toothache, backache or pain associated with trauma or surgery. the calmative properties may be especially useful in the treatment of tension headache, migraine and period pain and the antipyretic properties may be useful in controlling fever. mersyndol is a suitable alternative for those individuals who cannot tolerate aspirin.

Australia - English - Department of Health (Therapeutic Goods Administration)

sigma company limited - codeine phosphate hemihydrate, quantity: 15 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; colloidal anhydrous silica; povidone; ethanol; purified water; potato starch; docusate sodium - for the temporary relief of acute moderate pain in patients over the age of 12 years (see also contraindications and paediatric use).

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate,doxylamine succinate,paracetamol -

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - doxylamine succinate, quantity: 5.1 mg; codeine phosphate hemihydrate, quantity: 10 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; hyprolose; maize starch; pregelatinised maize starch; magnesium stearate; purified talc; stearic acid; povidone; sodium lauryl sulfate - for the temporary relief of acute moderate pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; magnesium stearate - aspen codeine tablets are indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: povidone; pregelatinised maize starch; croscarmellose sodium; maize starch; potassium sorbate; microcrystalline cellulose; stearic acid; magnesium stearate; purified talc - comfarol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Malta - English - Medicines Authority

chefaro ireland dac the sharp building, hogan place, dublin 2,, ireland - codeine phosphate, hemihydrate, caffeine, paracetamol - effervescent tablet - codeine phosphate hemihydrate 8 mg caffeine 30 mg paracetamol 500 mg - analgesics